IP Library › Patent Application 18384564
Patent Application
App. No. 18/384,564

HYDROGEL IMPLANTS FOR LOWERING INTRAOCULAR PRESSURE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/384,564
Abstract

Provided herein are sustained release biodegradable ocular hydrogel implants which are useful for lowering ocular pressure and for treating related conditions.

Claims (7)

1 . A sustained release biodegradable intracameral hydrogel implant comprising travoprost and a polymer network.

2 . The hydrogel implant of claim 1 , wherein the polymer network comprises a plurality of polyethylene glycol (PEG) units.

3 - 24 . (canceled)

25 . A method of treating ocular hypertension in a subject in need thereof comprising administering the hydrogel implant of any one of claims 1 to 2 to the eye of a subject.

26 . A method of treating glaucoma in a subject in need thereof comprising administering the hydrogel implant of any one of claims 1 to 2 to the eye of a subject.

27 . The method of claim 26 , wherein the glaucoma is open angle glaucoma.

28 . The method of claim 27 , wherein essentially no endothelial damage occurs following administration of a disclosed implant.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2024
From: GOLDSTEIN, MICHAEL; DRISCOLL, ARTHUR; BLIZZARD, CHARLES D.; DESAI, ANKITA
To: OCULAR THERAPEUTIX, INC.
Reel/Frame 068498/0302 →